Tag Archives: vaccination

Updated Guidelines for Prevention of Perinatal Hepatitis B

Advisory Committee on Immunization Practices (ACIP) and the Centers for Disease Control and Prevention (CDC) published a summary of existing recommendations and provided updated and new recommendations on the prevention of hepatitis B virus infection in the United States.

The new and updated recommendations are:

General Recommendations:

  • For all medically stable infants weighing ≥2,000 grams at birth and born to HBsAg-negative mothers, the first dose of hepatitis B vaccine should be administered within 24 hours of birth.
  • Permissive language for delaying the birth dose that was previously used in the recommendations has been removed.

Identification and Management of HBV-Infected Pregnant Women:

  • All hepatitis B surface antigen (HBsAg) positive pregnant women should be tested for hepatitis B DNA to guide the use of maternal antiviral therapy during pregnancy for the prevention of hepatitis B virus transmission.
    • A brief summary of the American Association for the Study of Liver Diseases (AASLD) guidelines for the use of maternal antiviral therapy to reduce perinatal Hepatitis B virus transmission is also included in the MMWR.

Management of Infants Born to Women Who Are HBsAg-Positive:

  • Infants born to women for whom HBsAg testing results during pregnancy are not available but have other evidence suggestive of maternal hepatitis B virus infection (presence of maternal HBV DNA, maternal HBeAg is positive, or the mother is known to be chronically infected with hepatitis B) should be managed as if born to an HBsAg-positive mother.
  • For infants who are transferred to a different facility after birth, staff at the transferring and receiving facilities should communicate with each other regarding the infant’s HepB vaccination and receipt of hepatitis B immune globulin (HBIG) to ensure prophylaxis is administered in a timely manner.

Management of Infants Born to Women with Unknown HBsAg Status

  • If it is not possible to determine the mother’s HBsAg status (e.g., where confidential safe surrender of infant occurs shortly after birth), the vaccine series should be completed according to the recommended schedule for infants born to HBsAg-positive mothers. Post-vaccination serologic testing and revaccination, if needed, is recommended for these infants.
  • For HBsAg-negative infants born to HBsAg-positive women who show no serologic immune response after receiving the initial HepB vaccine series, revaccinate the infant with a single challenge dose of HepB vaccine and repeat serologic testing (HBsAg and anti-HBs) one to two months later. If the infant remains HBsAg negative and has an anti-HBs of <10 mIU/mL following single dose revaccination, complete the second series on schedule with the two additional Hep B vaccine doses followed by post-vaccination serologic testing one to two months after the final dose.
    • Alternatively,basedonclinicalcircumstancesorparentpreference,HBsAg-negative infants born to HBsAg-positive women who show no serologic immune response after receiving the initial HepB vaccine series may instead be revaccinated with a second 3- dose series and retested one to two months after the final dose of vaccine.
    • As a reminder, post vaccination serologic testing of the infant should include HBsAg and anti-HBs. Anti-HBs testing should be performed using a method that allows detection of the protective concentration of anti-HBs (> 10mIU/mL).

Cases of Mumps Identified in Morgan County

Two cases of mumps, a vaccine preventable communicable viral disease, were identified in Morgan County.

Mumps, an acute vaccine-preventable viral illness transmitted by respiratory droplets and saliva, has an incubation period of 16–18 days (12–25 days min/max respectively). A statewide notification is being sent since the cases are widespread across the Morgan County community and a common exposure has not been identified. Continue reading

Visitor Restrictions in effect Jan 9th – Influenza

Visitor Restrictions

Centegra Health System is experiencing increased cases of influenza and flu-related hospitalizations. For the safety of hospital patients, visitors and Associates during this flu season, We are asking for your cooperation once again with the implementation of our visitor restriction policy.

This policy will go in to effect Thursday, Jan. 9, 2014:

  1. No visitors under the age of 18 years old
  2. Limited visitation for significant others in obstetrics and pediatrics.
  3. No visitors who are sick with a runny nose, sore throat, or fever

This is the second year we have implemented additional restrictions to our visitation policy. As an organization we believe it our responsibility to make every effort to reduce the spread of this illness. Please reinforce with your patients, and other with whom you interact in our facilities, our intentions to with these temporary restrictions.

Mandatory Medical Staff Vaccination

Vaccination is mandatory for all Associates and medical staff. To schedule your vaccination, please call Associate Health at 815-759-4372. Verification of vaccination is required and can be faxed to any of the numbers below:

  • CHM Medical Staff Office Fax: 815-759-8098
  • CHW Medical Staff Office Fax: 815-334-3856
  • Associate Health Fax: 815-759-4425

We would like to remind all clinicians of the importance of hand washing, masks and other appropriate measures to prevent the spread of flu. Likewise, for the safety of your other patients, consider expeditious discharge as soon as appropriate to prevent risk of infection to them as well as their families. Your cooperation is greatly appreciated and your patients will appreciate it as well.


Where can I find past immunization history?

Past information such as immunizations, implants, procedures can be found in the patient profile.

  • Patient profile can be accessed through the reports tab.

  • Now select “Patient Profile” from the drop down menu.

  • Select immunization from the list.


  • The vaccine, dose and administration date should be available.
Physician vaccination 2013

Mandatory influenza vaccination for physicians

In our effort to enhance patient and healthcare provider safety, last year Centegra Health System (CHS) made the influenza vaccination mandatory for all Associates.  The program was a huge success in vaccinating over 95% of associates. This season all physicians are expected to participate in this Medical Executive Committee (MEC) approved initiative to increase our patient safety.

Research shows that vaccination is the single most important measure for reducing the impact of influenza not only on ourselves but our community as well. It is therefore our responsibility as healthcare workers to do the right thing for our patients. The Center for Disease Control, IDPH and The Joint Commission both highly recommend flu shots for all health care workers and many progressive healthcare organizations both locally and nationally have seen positive outcomes as a result of mandatory flu shot programs.

CHS requires all associates, physicians, volunteers, students, clinical contract workers, and identified vendors to receive an influenza vaccination in order to protect patients, Associates, family members, and the community from influenza. Exceptions will only be granted for medical conditions and religious beliefs. Both will require written documentation. Associates previously granted exemptions are required to complete a exemption renewal. Please review the updated CHS Influenza Immunization Program policy for details.

In that regard we are offering influenza vaccinations free to all Physicians, Licensed Independent Practitioners, Associates, volunteers, and students. Please review the attached poster detailing the vaccination schedule.

If you will be receiving your vaccination through your practice we will need you to complete the attached form and submit it to the Medical Staff Office.


Risk of Guillain-Barré syndrome after seasonal influenza vaccination – Lancet study

The risk of Guillain-Barre is often viewed as an obstacle to influenza vaccination.

A recent study by Kwong et al published in the June 28th issue of the Lancet identified cases of Guillain-Barre that occurred with 6 weeks of vaccination and found that more cases occurred in the control group (not vaccinated) than in those who were vaccinated. Far greater number of Guillain-Barre cases were identified in the non-vaccinated group than in the ones vaccinated.

The conclusion reached was that the attributable risk for Guillain-Barre after seasonal inflluenza vaccination is lower than those after influenza disease itself. This study was funded by the Canadian Institute of Health Research.


Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study; Dr Jeffrey C Kwong MD,Priya P Vasa MD,Michael A Campitelli MPH,Steven Hawken MSc,Kumanan Wilson MD,Laura C Rosella PhD,Prof Therese A Stukel PhD,Natasha S Crowcroft MD(Cantab),Prof Allison J McGeer MD,Lorne Zinman MD,Shelley L Deeks MD The Lancet Infectious Diseases – 28 June 2013 DOI: 10.1016/S1473–3099(13)70104-X]